Bayer recommends thorough cost benefit analysis prior to REACH submission.
This blog discusses the importance of cost-benefit analysis in the REACH registration process, emphasizing the need to assess tonnage, usage, and potential profits. It highlights the strategic nature of regulatory compliance and the impact on a company's portfolio.